SCHEMBL25229393

SCHEMBL25229393

Cc1ccccc1-c1cc(=O)oc2nc(N(C)C(C)C(N)=O)ccc12

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KCNA3 P22001 3/20 0.39
▸ IKBKB O14920 1/20 0.36
▸ PKM P14618 1/20 0.34
▸ CA12 O43570 2/20 0.33
▸ CA9 Q16790 2/20 0.33
▸ ALDH1A1 P00352 3/20 0.33
▸ HPGD P15428 3/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ LDHA P00338 1/20 0.33
▸ USP2 O75604 1/20 0.33
▸ GPBAR1 Q8TDU6 4/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ GRM2 Q14416 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32
▸ CYP2C9 P11712 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ PSMD14 O00487 1/20 0.32
▸ MMP2 P08253 1/20 0.32
▸ BLM P54132 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30440719 1.00 KCNA3 (0.39) KCNA3IKBKBPKMCA12CA9
SCHEMBL25271730 0.90 KCNA3 (0.42) KCNA3PKMCA12CA9ALDH1A1
SCHEMBL30440359 0.90 KCNA3 (0.35) KCNA3CA12CA9ALDH1A1HPGD
SCHEMBL25271729 0.90 KCNA3 (0.42) KCNA3PKMCA12CA9ALDH1A1
SCHEMBL25272915 0.90 KCNA3 (0.35) KCNA3CA12CA9ALDH1A1HPGD
SCHEMBL25234441 0.88 KCNA3 (0.38) KCNA3PKMALDH1A1HPGDKDM4E
SCHEMBL25271228 0.88 KCNA3 (0.38) KCNA3PKMALDH1A1HPGDKDM4E
SCHEMBL25281739 0.83 KCNA3 (0.39) KCNA3IKBKBPKMCA12CA9
SCHEMBL25272932 0.83 KCNA3 (0.46) KCNA3PKMCA12CA9ALDH1A1
SCHEMBL25281771 0.82 KCNA3 (0.39) KCNA3IKBKBPKMCA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250066377-A1 AMINO CHROMEN-2-ONE MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2025-02-27 — — US disclosed
WO-2023114539-A1 AMINO CHROMEN-2-ONE MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2023-06-22 — — WO disclosed
WO-2023114539-A1 AMINO CHROMEN-2-ONE MODULATORS OF POLRMT PRETZEL THERAPEUTICS, INC. (US) 2023-06-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250066377-A1 AMINO CHROMEN-2-ONE MODULATORS OF POLRMT POLRMT, TFAM, POLM KCNA3 4324/4885IKBKB 3253/4885PKM 241/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback